Neuralink: Here is Why US Lawmakers Are Asking SEC to Launch Fraud Investigation Into Elon Musk

Four U.S. lawmakers have raised concerns about the safety of Neuralink's brain implant, pushing for an SEC investigation into Elon Musk's alleged securities fraud.

The lawmakers, including Earl Blumenauer, Jim McGovern, Barbara Lee, and Tony Cardenas, submitted a letter to the SEC, urging a closer look into Musk's statements regarding the safety of the innovative technology.

Safety Issues and Animal Testing Controversy

The call for an investigation revolves around the safety protocols of Neuralink's groundbreaking brain implant.

As the company gears up for its first human trials, scrutiny intensifies over alleged misleading information provided by Musk.
The lawmakers cite veterinary records from Neuralink's monkey experiments, revealing "debilitating health effects" such as paralysis, seizures, and brain swelling.
Shockingly, the letter notes that at least 12 monkeys were euthanized due to problems with the implants.

Musk's Downplaying Raises Eyebrows

Despite the concerning findings, Musk, also Neuralink's CEO, downplayed the severity of the animal testing results.
In a post on his social media site, X, Musk claimed, "no monkey has died as a result of a Neuralink implant," emphasizing the selection of "terminal" monkeys to minimize risks.
The lawmakers argue that Musk's statements may have violated SEC rules by denying a direct connection between animal deaths and the safety of Neuralink's brain-computer interface.

Lawmakers Allege Rushed Surgeries and Pressure from Musk

The lawmakers' concerns are not isolated incidents. Last year, Neuralink faced accusations from its own employees, revealing rushed and botched surgeries on animals, including monkeys, pigs, and sheep.
The urgency stemmed from Musk's insistence on accelerating the process to meet the safety data requirements set by the U.S. Food and Drug Administration (FDA) for human testing authorization.
In a surprising move, Neuralink announced FDA clearance for its first-in-human clinical trial in May. However, the lack of transparency regarding the trial's details has raised eyebrows.
The SEC investigation is set to dive into whether Musk's actions, statements, and the company's overall approach comply with securities regulations and ethical standards.

FAQs:

Q1:What is the potential benefit of Neuralink?
A1: Neuralink holds the potential to empower individuals with spinal cord injuries, facilitating limb movement. Beyond that, it could serve as an effective cure for paralysis, blindness, mental illness, and neurological conditions like Alzheimer's and dementia.

Q2: Who provided funding for Neuralink?
A2: Neuralink received its most substantial capital financing in a round led by Peter Thiel's Founders Fund, securing an impressive $280 million.